In summary, our study suggests that the collaboration of PML-RARα with elevated TRIB3 expression inhibits PPARγ activity and causes lipid metabolism abnormalities in newly diagnosed APL patients. The gene discussed is PPARG; the disease is acute promyelocytic leukemia.